Imelda Cotton
Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.
Cornish Metals secures £28.6 million government investment to restart historic South Crofty tin mine
The UK’s National Wealth Fund (NWF) has announced a £28.6 million direct equity investment into Cornish Metals (TSX-V: CUSN) to help finance and de-risk the re-opening of the South Crofty tin mine in Cornwall. The fully-permitted underground development hosts one of the world’s highest-grade tin resources and racked up more than 400 years of recorded […]
Base Resources receives $375m takeover bid from Energy Fuels to create global critical minerals group
US-based critical minerals producer Energy Fuels has made a takeover bid for Australian company Base Resources (ASX: BSE) to create a billion-dollar global business with a focus on rare earth elements, uranium and mineral sands production. Under the terms of the proposal, Base shareholders will receive 0.026 Energy Fuels shares for each Base share held […]
Keywords Studios sees revenue jump following strategic acquisitions
Irish video game service provider Keywords Studios (LSE: KWS) has cited robust organic growth and multiple acquisitions for a 13% jump in 2023 full-year revenue to approximately £666 million, from £590 million in the previous year. The company’s adjusted operating profit rose 6% to £104 million with a 15.6% margin, which was ahead of its […]
Mike Ashley joins Hornby as consultant amid Frasers Group’s increased stake
International models and collectibles group Hornby has engaged retail tycoon Mike Ashley as a consultant to the company. The appointment comes one month after it was revealed that Mr Ashley’s company Frasers Group had upped its stake as a strategic shareholder. Mr Ashley will provide the services to the toy company through his wholly-owned company […]
Poolbeg Pharma moves closer to granting of patent for POLB 001 to treat multiple diseases
UK biopharmaceutical company Poolbeg Pharma (AIM: POLB) has received a notice of allowance from the US Patent Office in relation to an application for its lead candidate POLB 001 in the treatment of multiple diseases. The notice covers a class of drugs (including POLB 001) for treating hypercytokinaemia (cytokine storm) and for preventing its development […]
Faron Pharma reports improved remission rates from Bexmab Phase 1 trial to treat patients with aggressive cancers
Faron Pharmaceuticals (LSE: FARN) has reported positive data from Phase 1 of an ongoing trial investigating bexmarilimab (Bexmab) in combination with standard of care in aggressive hematological malignancies of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Four out of five initial Phase 1 patients have now been on Bexmab with azacitidine for more than […]
Sign In Solutions makes £28.35m cash bid for SmartSpace Software
Sign In Solutions subsidiary Welcome UK Bidco has made a £28.35 million cash offer for technology business SmartSpace Software (LSE: SMRT) by way of a court-sanctioned scheme of arrangement. SmartSpace designs and builds smart software solutions such as visitor, desk and meeting room management to help transform employee engagement. Under the terms of the deal, […]
Vodafone Group to divest Italian business in US$8.71b deal with Swisscom
Vodafone Group Plc (LSE: VOD) has announced it will divest its subsidiary Vodafone Italy to Switzerland-based telco Swisscom AG. The US$8.71 billion transaction follows an extended period of engagement with several companies to explore market consolidation options in Italy. It comes hot on the heels of Vodafone Spain’s divestment in October to Zegona Communications plc […]
China’s JD.com becomes second suitor to walk away from takeover bid for Currys
Chinese e-commerce giant JD.com (also known as Jingdong) has walked away from a takeover tussle for British appliance and electronics chain Currys plc (LSE: CURY). In a brief statement released last week, the company said it would no longer pursue an offer for the High Street brand, less than one month after entering the race. […]
Ondine Biomedical’s Steriwave antimicrobial to be rolled out in eight new healthcare facilities
Ondine Biomedical (LSE: OBI) has announced that its Steriwave nasal photodisinfection and chlorhexidine skin decolonisation technology will be deployed in eight new healthcare facilities worldwide, including six hospitals. The commercial deals are paid adoptions which had begun or were agreed to before the end of February. The first three are at hospitals in Spain and […]
AstraZeneca spends US$1.05b to acquire Amolyt Pharma and boost its rare disease portfolio
Global pharmaceutical company AstraZeneca (LSE: AZN) will part with US$1.05 billion to buy-out French biotech Amolyt Pharma, which is focused on the development of novel treatments for rare endocrine diseases. Under the terms of the transaction, AstraZeneca will acquire all of Amolyt’s outstanding shares on a cash and debt-free basis. It will include an US$800 […]
NetScientific reports profitable year ahead of shift in venture capital trends to deep tech
Deep tech and life sciences venture capital investment group NetScientific plc (LSE: NSCI) has lodged a proprietary trade profit of approximately £427,000 and an increase in capital under advisory to £23.5 million for the year ended 31 December. The group – which has a portfolio of 23 companies — also reported the raising of £52.2 […]
OptiBiotix Health signs £7m deal to market SlimBiome in India
Life sciences business OptiBiotix Health (LSE: OPTI) has signed a £7 million agreement to market its patented SlimBiome ingredient in India under the Dr Morepen brand. Dr Morepen is a wholly-owned subsidiary of prominent Indian pharmaceutical company Morepen Laboratories, launched in 2001 to encourage customers to be in charge of their own health and well-being. […]
Central banks hit quarterly record for buying gold
Central banks have stepped up their purchases of gold this year, according to the latest figures from the World Gold Council (WGC). The September quarter saw the banks buy a record 399 tonnes of gold worth around US$20 billion, helping to lift global demand for the metal to 1,181t and representing a 28% increase from […]
Cameco partners with Brookfield in acquisition of Westinghouse Electric
Canadian uranium giant Cameco Corporation (NYSE: CCJ) and clean energy investor Brookfield Renewable Partners (NYSE: BEP, BEPC) have announced they will join forces on the acquisition of global nuclear services business Westinghouse Electric Company. The acquisition gives Westinghouse a total enterprise value of almost $8 billion. Under the arrangement, Cameco’s expertise in the nuclear industry […]
US launches US$4.3b plan to reduce reliance on Russian uranium imports
The US Government is pushing legislators to support a US$4.3 billion plan to reduce the nation’s reliance on enriched uranium imports from Russia by promoting direct purchases from domestic producers. The proposal would see the government act as a guaranteed buyer of domestic enriched uranium production and aims to spur development of enrichment and other […]
Alien Metals to acquire Vivash Gorge iron ore project from Zenith Minerals
Alien Metals (LSE: UFO) has entered a binding heads of agreement the Australian explorer Zenith Minerals (ASX: ZNC) to acquire 100% of the Vivash Gorge iron ore project in Western Australia. The project covers approximately 47 square kilometres in the Pilbara region and is strategically located 60km south of Alien’s Brockman iron project. Under the […]
US House of Representatives passes bill to decriminalise cannabis nationwide
The US House of Representatives has cleared a bill to decriminalise cannabis, paving the way for the drug to be legalised across North America and removed from the list of controlled substances. The Marijuana Opportunity Reinvestment and Expungement (or MORE) Act promises to eliminate non-violent federal marijuana convictions for anyone who manufactures, distributes or possesses the substance. It […]